Tables and figures

Table 1
Breast cancer deaths averted, mortality reduction, life-years (LY) saved, screening examinations per woman, women needed to be screened per death averted, and women needed to be screened per LY gained, compared with No Screening, by screening strategy

Table 2
Number of screening examinations, number of recalls for non-invasive imaging and no cancer found, and number of negative biopsies, per 1,000 women alive at age 40, by screening strategy

Text table 1
Digitial mammography screening strategies modelled

Text table 2
Mortality reduction associated with adjuvant treatment, by receptor status, age range, and breast cancer stage

Figure 1
Age-specific breast cancer incidence rate per 100,000, by stage, for No Screening and annual screening at ages 50 to 74

Figure 2
Age-specific mortality rate per 100,000 for No Screening, biennial screening at ages 50 to 74, and annual screening at ages 40 to 49 followed by biennial screening at ages 50 to 74

Figure 3
Breast cancer deaths averted per 1,000 women alive at age 40, by number of lifetime screens per woman

Figure 4
Life-years saved (undiscounted) per 1,000 women alive at age 40, by number of lifetime screens per woman

Date modified: